| RELVX | RGTFX | RELVX / RGTFX | |
| Total Expense Ratio | 1.43 | 0.59 | 242% |
| Annual Report Gross Expense Ratio | 1.67 | 0.59 | 283% |
| Fund Existence | 28 years | 10 years | - |
| Gain YTD | 14.464 | 17.875 | 81% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 313M | 6.93B | 5% |
| Annual Yield % from dividends | 1.84 | 0.73 | 253% |
| Returns for 1 year | 12.64 | 13.44 | 94% |
| Returns for 3 years | 46.40 | 47.99 | 97% |
| Returns for 5 years | 40.77 | 32.14 | 127% |
| Returns for 10 years | 65.59 | 85.05 | 77% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EXOSX | 36.12 | N/A | N/A |
| Manning & Napier Overseas Series I | |||
| GGOIX | 22.36 | N/A | N/A |
| Goldman Sachs Mid Cap Growth Instl | |||
| IVGTX | 10.87 | N/A | N/A |
| VY® Morgan Stanley Global Franchise S | |||
| MINGX | 44.00 | -0.02 | -0.05% |
| MFS International Intrinsic Value R3 | |||
| GAOFX | 21.94 | -0.03 | -0.14% |
| JPMorgan Global Allocation R4 | |||